We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Gastrointestinal bleeding
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Background and aims
Internal bleeding from the stomach and the gut may show as vomiting up blood. It may also show as passing blood in the toilet. Sometimes you can see the blood clearly in the toilet, and sometimes it is there but it cannot be seen. This study aims to determine if this internal bleeding changes from year to year - whetjher it changes with age, smoking, and use of alcohol, and whether it changes with the use of certain drugs.
Who can participate:
Adults suffering from internal stomach or gut bleeding
What does the study involve?
There will be no direct participation from participants, as this study is a review of previous cases of internal bleeding (1996 to present) and new cases from now until 2026. Patient details will be kept confidential and anonymous. Records will be reviewed for changes in various factors over time, including patient demographics, other illness, causes and nature of bleeding, drugs taken and whether patients have had surgery, amongst various other factors.
What are the possible benefits and risks of participating?
The possible benefit of taking part in this study is that the results could improve future treatment of patients with internal bleeding, and this may help to train doctors. There are no known risks to participants taking part in this study, as it does not require direct participation.
Where is the study run from?
Gastroenterology Unit at University Hospital Crosshouse, Kilmarnock, Scotland (UK)
When is the study starting and how long is it expected to run for?
January 2002 to December 2026
Who is funding the study?
Gastroenterology Endowment Fund, University Hospital Crosshouse, NHS Ayrshire and Arran, Scotland (UK)
Who is the main contact?
Professor Ali S Taha
ali.taha1@btinternet.com.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
2020 Poster results in https://doi.org/10.1016/s0016-5085%2820%2932157-0 abstract/poster (added 22/01/2021)
You can take part if:
You may not be able to take part if:
1. History of previous gastrointestinal surgery2. Current pregnancy3. Current use of cytotoxic drugs
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Prof
Ali
Taha
44-1563-827280
ali.taha1@btinternet.com
The study is sponsored by Gastroenterology Endowment Fund and funded by Gastroenterology Endowment Fund.
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
